Skip to main content
. 2023 Nov 20;11(2):2302776. doi: 10.1002/advs.202302776

Table 1.

Therapeutic index.

Drug HIF1α degradation a) (IC50, µM) Normal cell cytotoxicity b) (IC50, µM) Therapeutic index (B/A)
MitoQ 0.077 ± 0.016 22.47 ± 0.46 295.81
SB‐U014 0.040 ± 0.091 27.47 ± 0.77 694.92
SB‐U015 0.041 ± 0.083 31.78 ± 0.76 773.05
a)

IC50 values of HIF1α protein degradation in MIO‐M1 cells upon TRAP1 inhibitor treatment were analyzed as in Figure 7A,B (n = 4);

b)

IC50 values of the cytotoxic activities of the drugs in primary Müller cells were calculated as in Figure S18A, Supporting information (n = 4). The therapeutic index[ 42 ] was determined as (IC50 for normal cell cytotoxicity)/(IC50 for HIF1α degradation). Data information: Data are expressed as mean ± SEM.